share_log

BioVie | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

BioVie | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

BioVie | S-1/A：證券上市註冊聲明(修正)
美股SEC公告 ·  2024/11/28 04:18

Moomoo AI 已提取核心訊息

On November 27, 2024, BioVie filed Amendment No. 1 to its Form S-1 Registration Statement with the SEC. This amendment was made to correct a scrivener's error in Exhibit 5.1 regarding the aggregate total being registered. The amendment includes only the facing page, explanatory note, Item 16(a) of Part II, the signature page, and the corrected Exhibit 5.1. The rest of the Registration Statement remains unchanged. BioVie is classified as a non-accelerated filer and a smaller reporting company. The company has not elected to use the extended transition period for complying with new or revised financial accounting standards. The registration statement will become effective as determined by the SEC under Section 8(a) of the Securities Act of 1933.
On November 27, 2024, BioVie filed Amendment No. 1 to its Form S-1 Registration Statement with the SEC. This amendment was made to correct a scrivener's error in Exhibit 5.1 regarding the aggregate total being registered. The amendment includes only the facing page, explanatory note, Item 16(a) of Part II, the signature page, and the corrected Exhibit 5.1. The rest of the Registration Statement remains unchanged. BioVie is classified as a non-accelerated filer and a smaller reporting company. The company has not elected to use the extended transition period for complying with new or revised financial accounting standards. The registration statement will become effective as determined by the SEC under Section 8(a) of the Securities Act of 1933.
2024年11月27日，BioVie向美國證券交易委員會提交了其S-1表格註冊聲明的第1號修正案。該修正案旨在更正附錄5.1中抄寫員關於註冊總額的錯誤。修正案僅包括對頁、解釋性說明、第二部分第16（a）項、簽名頁和更正後的附錄5.1。註冊聲明的其餘部分保持不變。 BioVie被歸類爲非加速申報人和規模較小的申報公司。該公司沒有選擇使用延長的過渡期來遵守新的或修訂的財務會計準則。註冊聲明將根據美國證券交易委員會根據1933年《證券法》第8（a）條的規定生效。
2024年11月27日，BioVie向美國證券交易委員會提交了其S-1表格註冊聲明的第1號修正案。該修正案旨在更正附錄5.1中抄寫員關於註冊總額的錯誤。修正案僅包括對頁、解釋性說明、第二部分第16（a）項、簽名頁和更正後的附錄5.1。註冊聲明的其餘部分保持不變。 BioVie被歸類爲非加速申報人和規模較小的申報公司。該公司沒有選擇使用延長的過渡期來遵守新的或修訂的財務會計準則。註冊聲明將根據美國證券交易委員會根據1933年《證券法》第8（a）條的規定生效。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    ImmunoPrecise Antibodies
    IPA
    -- 0.653
    Nutriband
    NTRB
    -- 6.750
    Absci Corp
    ABSI
    -- 4.170
    Seres Therapeutics
    MCRB
    -- 0.930
    Rein Therapeutics
    RNTX
    -- 2.440
    解鎖完整榜單
    熱門討論
    特朗普2.0時代開啓，全球股市新風口在哪裏？
    ▪️加密貨幣政策能否利好crypto? ▪️關稅政策能否利好中概等海外資產？ ▪️在特朗普政策下，有哪些投資機會值得關注？ 展开
    離川普上臺只有7天了～
    熱門中概股
    追蹤最熱門的中概股實時資訊。